0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
RSS Email Alerts
Please Wait... Processing your request... Please Wait.

Original Investigation | 
Rohan Khera, MD; Mohammad Hassan Murad, MD, MPH; Apoorva K. Chandar, MBBS, MPH; et al.
JAMA. 2016;315(22):2424-2434. doi:10.1001/jama.2016.7602.
Includes: Supplemental Content

Viewpoint |  ONLINE FIRST
Richard Kronick, PhD; Sharon Arnold, PhD; Jeffrey Brady, MD, MPH
JAMA. Published online June 13, 2016. doi:10.1001/jama.2016.7887

News From the Food and Drug Administration | 
Rebecca Voelker, MSJ
JAMA. 2016;315(21):2268. doi:10.1001/jama.2016.6558.

From the JAMA Network | 
Anthony D. Yang, MD; Karl Y. Bilimoria, MD, MS
JAMA. 2016;315(19):2113-2114. doi:10.1001/jama.2016.5422.

Medical News & Perspectives | 
Bridget M. Kuehn, MSJ
JAMA. 2016;315(18):1934-1936. doi:10.1001/jama.2016.2752.

News From the Food and Drug Administration | 
Rebecca Voelker, MSJ
JAMA. 2016;315(17):1826. doi:10.1001/jama.2016.4409.

Original Investigation | 
Katherine E. Fleming-Dutra, MD; Adam L. Hersh, MD, PhD; Daniel J. Shapiro; et al.
JAMA. 2016;315(17):1864-1873. doi:10.1001/jama.2016.4151.
Includes: CME, Supplemental Content

Viewpoint | 
Tejal K. Gandhi, MD, MPH; Donald M. Berwick, MD, MPP; Kaveh G. Shojania, MD
JAMA. 2016;315(17):1829-1830. doi:10.1001/jama.2016.1759.

Viewpoint | 
Ashish Jha, MD, MPH; Peter Pronovost, MD, PhD
JAMA. 2016;315(17):1831-1832. doi:10.1001/jama.2016.3448.

Viewpoint | 
Stephen O. Agboola, MBBS, MPH; David W. Bates, MD, MSc; Joseph C. Kvedar, MD
JAMA. 2016;315(16):1697-1698. doi:10.1001/jama.2016.2402.

Sign in

Purchase Options

• Subscribe to the journal
• Rent this article ?

A free personal account provides

• Free current issues on The JAMA Network Reader
• Free quizzes on The JAMA Network Challenge
• Commenting and personalized alerts
From The JAMA Network
JAMA Oncology
Invited Commentary  | 
Cardiac Protection in HER2-Targeted Treatment How Should We Measure New Strategies?
Ana Barac, MD, PhD; Sandra M. Swain, MD
JAMA Oncology
Original Investigation  | 
Angiotensin II–Receptor Inhibition With Candesartan to Prevent Trastuzumab-Related Cardiotoxic Effects in Patients With Early Breast Cancer A Randomized Clinical Trial
Annelies H. Boekhout, PhD; Jourik A. Gietema, MD, PhD; Bojana Milojkovic Kerklaan, PhD; et al.
JAMA Internal Medicine
Invited Commentary  | 
Habitual Prescribing of Laxatives—It’s Time to Flush Outdated Protocols Down the Drain
Kanako Y. McKee, MD; Eric Widera, MD
JAMA Internal Medicine
Teachable Moment  | 
Massive Rectal Hemorrhage After Prostate Biopsy A Teachable Moment
Justin C. Laracy, MD; Ricky Regalbuto, MD; Brian L. Block, MD